TrueMAB™ Monoclonal Antibodies
Made against Authentic Protein Antigens
TrueMAB™ Antibody Features
TrueMAB™ antibodies are superior monoclonal antibodies made against authentic protein antigens (mostly full-length proteins expressed in human cell lines) and thus are able to recognize the native epitope(s) of the protein target. This feature makes TrueMAB a great tool for immunoassays that are sensitive to proteins’ conformations, such as IF/ICC, IP, flow, ELISA, IHC, high content screening (HCS), etc.
- Western blot on cell lysates (9 cell lines with a positive control)
- Immunohistochemistry on 24 human normal and tumor FFPE tissues
- Immunofluorescent staining
- Flow cytometry
A positive control is available at nomimal cost for Every TrueMAB™ antibody if applicable, which is the HEK293 over-expression lysate of the target protein. This lysate can serve as the positive control in Western blot.
Cell lines and FFPE tissues for TrueMAB™ validation:
Cell lines: HeLa (human), HepG2 (human), COS7 (monkey), PC12 (rat), A549 (human), HT29 (Human), MDCK (canine), Jurkat (human), HEK293T (human), MCF-7 (human), SVT2 (mouse)
FFPE human normal tissues: paraffin-embedded human breast tissue, human colon tissue, human kidney tissue, human liver tissue, human lung tissue, human ovary tissue, human pancreas tissue, human thyroid tissue, human endometrium tissue, human prostate tissue, human bladder tissue, human lymph node tissue
FFPE human tumor tissues: paraffin-embedded adenocarcinoma of human breast tissue, adenocarcinoma of human colon tissue, carcinoma of human kidney tissue, carcinoma of human liver tissue, carcinoma of human lung tissue, adenocarcinoma of human ovary tissue, carcinoma of human pancreas tissue, carcinoma of human thyroid tissue, adenocarcinoma of human endometrium tissue, carcinoma of human prostate tissue, carcinoma of human bladder tissue, human lymphoma tissue
Immunofluorescent staining of transiently transfected COS7 cells